Tumour type | Number | p62 | Beclin-1 | LC3B | ULK1 | Clinical relevance | References |
---|---|---|---|---|---|---|---|
Gastric adenocarcinoma | 61 | Positive nuclear 57 % Positive cytoplasmic 61 % | – | – | – | p62: High p62 expression associated with low differentiation grade but less lymph node metastasis | [26] |
510 | Positive 49.2 % | Positive 24.7 % | Positive 15.5 % | – | Autophagy (defined as at least two of three markers positive) was associated with poor survival | [42] | |
 | 75 | – | Positive 70.6 % | – | – | No survival analysis performed. Increased Beclin-1 expression in well differentiated gastric cancer compared to normal mucosa. Decreased Beclin-1 expression in poorly differentiated gastric cancer | [43] |
Pancreatic adenocarcinoma | 18 | Positive nuclear 78 % Positive cytoplasmic 56 % | – | – | – | p62: none | [26] |
73 | Â | Positive 47.9Â % | Positive 83.3Â % | Â | Beclin-1 overexpression was associated with poor prognosis | [44] | |
63 | Â | Positive 22.2Â % | Â | Â | Beclin-1 overexpression was associated with favourable prognosis | [45] | |
Intrahepatic cholangiocarcinoma | 108 | – | Strong expression 24.1 %, 48,1 % moderate and 27.8 % weak/negative expression | – | – | Low Beclin-1 expression was associated with worse OS and DFS. Low Beclin-1 expression correlated with lymph node metastasis | [46] |
Oesophageal adenocarcinoma | 116 | – | – | High p62 81 % High LC3B 83.6 % | – | Low LC3B and low p62 cytoplasmic expression was associated with worse OS | [33] |